The ‘dengue belt’ stretches around much of the planet crossing continents, cultures and time zones, a vast region linked by a common fate: a mosquito-borne disease that can be prevented for...
New pills to treat patients with COVID-19 are currently in midstage clinical trials and, if successful, could be ready by the end of the year.
Only one treatment — remdesivir (Veklury) — has been fully...
ZURICH (Reuters) – Swiss drugmaker Roche said on Thursday adding its drug Actemra to Gilead Sciences’ Veklury medication, also called remdesivir, did not reduce hospital stays for patients...
(Reuters) – Europe’s drugs regulator said on Tuesday it was expecting to give an opinion before the summer on whether Gilead Sciences’ remdesivir can be used to treat COVID-19 patients...
Highly promising vaccines have recently emerged for COVID-19, but this doesn’t mean research into other treatments can slow down. There is still no cure for the disease, and people will likely continue...
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok